Form 4: Opaleye Management Inc. Increases Stake in Codexis, Inc.

Opaleye Management Inc. reports purchasing 100,000 shares of Codexis, Inc. at an average price of $1.9838, increasing its indirect holdings.

Summary

• Opaleye Management Inc., a 10% owner of Codexis, Inc. (CDXS), filed a Form 4 on April 9, 2025, reporting a transaction that occurred on April 8, 2025.
• Opaleye Management Inc. purchased 100,000 shares of Codexis common stock at a weighted average price of $1.9838 per share, with prices ranging from $1.9751 to $1.9899.
• Following the transaction, Opaleye Management Inc. indirectly owns 9,465,000 shares through Opaleye, L.P. and 250,000 shares through a Managed Account.
• Opaleye Management Inc. disclaims beneficial ownership of the shares except to the extent of its pecuniary interest.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine transaction disclosure. The increased stake could be seen as a positive signal, but it's not overtly bullish.

Positives

• Opaleye Management Inc.'s purchase indicates confidence in Codexis, Inc.

Management Comments

• Opaleye Management Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest.

Industry Context

This filing reflects ongoing investment activity in the biotechnology sector, where companies like Codexis are subject to scrutiny regarding ownership and insider transactions.

Comparison to Industry Standards

• Comparing Opaleye's investment activity to similar filings from other institutional investors in comparable biotech firms (e.g., ARK Investment Management's holdings in CRISPR Therapeutics or Fidelity's positions in Moderna) could provide context.
• Analyzing the size and frequency of these transactions relative to industry benchmarks for insider trading activity can offer insights into market sentiment and potential future performance.

Stakeholder Impact

• The increased stake by Opaleye Management Inc. could positively influence shareholder confidence.

Key Dates

Keywords

Opaleye Management Inc., Codexis, CDXS, Form 4, Beneficial Ownership, Stock Purchase, Investment